Le Lézard
Classified in: Covid-19 virus

Global Specialty Fats and Oils Market Report 2021: Market to Reach $19.1 Billion by 2027 - U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 10% CAGR - ResearchAndMarkets.com


The "Specialty Fats and Oils - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Specialty Fats and Oils Market to Reach $19.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Specialty Fats and Oils estimated at US$12.2 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 6.6% over the period 2020-2027.

Specialty Oils, one of the segments analyzed in the report, is projected to record 6.4% CAGR and reach US$11.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Specialty Fats segment is readjusted to a revised 6.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 10% CAGR

The Specialty Fats and Oils market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2027 trailing a CAGR of 9.9% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS (Total 55 Featured):

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/edvl61


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: